You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 159 No. 1, January 11, 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (20)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Prognosis/ Outcomes
 •Congestive Heart Failure/ Cardiomyopathy
 •Alert me on articles by topic

Assessing the Population Burden From Heart Failure

Need for Sentinel Population–Based Surveillance Systems

Arch Intern Med. 1999;159:15-17.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

IN PART because of the aging of the American population and improved survival following coronary heart disease, heart failure (HF) is assuming increasing public health and clinical importance. While few recent or population-based data are available to systematically characterize the present population burden from HF, estimates are that approximately 4.9 million Americans have a diagnosis of HF, about 400,000 new cases occur annually, and more than 43,000 individuals died of HF in the United States as recently as 1995,1-2 although death certificate data likely underestimate the contribution of this disease to overall and cause-specific mortality. Reflecting the ever-increasing magnitude of this condition and associated costs, the number of hospitalizations for HF rose from 377,000 in 1979 to 872,000 in 1995.1 Deaths attributed to HF increased by more than 100% between 1979 and 1995, and death rates in 1995 were highest for black men (8.8 per 100,000) followed by black women . . . [Full Text of this Article]


RELATED ARTICLE

Congestive Heart Failure in the Community: Trends in Incidence and Survival in a 10-Year Period
Michele Senni, Christophe M. Tribouilloy, Richard J. Rodeheffer, Steven J. Jacobsen, Jonathan M. Evans, Kent R. Bailey, and Margaret M. Redfield
Arch Intern Med. 1999;159(1):29-34.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Preemptive heme oxygenase-1 gene delivery reveals reduced mortality and preservation of left ventricular function 1 yr after acute myocardial infarction
Liu et al.
Am. J. Physiol. Heart Circ. Physiol. 2007;293:H48-H59.
ABSTRACT | FULL TEXT  

Molecular and Cell-Based Therapies for Protection, Rescue, and Repair of Ischemic Myocardium: Reasons for Cautious Optimism
Melo et al.
Circulation 2004;109:2386-2393.
FULL TEXT  

Epidemiology and clinical aspects of congestive heart failure
Murray-Thomas and Cowie
Journal of Renin-Angiotensin-Aldosterone System 2003;4:131-136.
ABSTRACT  

Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart Study
Lloyd-Jones et al.
Circulation 2002;106:3068-3072.
ABSTRACT | FULL TEXT  

Defining Diastolic Heart Failure : A Call for Standardized Diagnostic Criteria
Vasan and Levy
Circulation 2000;101:2118-2121.
FULL TEXT  

Long-Term Benefit of Primary Angioplasty as Compared with Thrombolytic Therapy for Acute Myocardial Infarction
Zijlstra et al.
NEJM 1999;341:1413-1419.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.